Title for MeetingAbstracts
Alphabetical listing of titles
CD4 cell decline precedes in vitro AZT resistance.
CD4 cell depletion, immune activation and viral load in HIV infection: from correlations to causal relationships.
CD4 cell expansion ex vivo predicts clinical responses to antiretroviral therapy.
CD4 CELL INCREASES THROUGH MORE THAN 4 YEARS IN ANTIRETROVIRAL-NAIVE HIV+ PATIENTS TREATED WITH LOPINAVIR/RITONAVIR-BASED THERAPY.
CD4 cells evolution in relation to the starting point of treatment with zidovudine in a cohort of hemophiliacs.
CD4 correlates of opportunistic infections in HIV-infected children during the pre-HAART era.
CD4 count and AIDS dementia complex.
CD4 count and predictors of mortality in a dually infected HIV/TB cohort in Africa.
CD4 count and pregnancy in HIV+ women.
CD4 count and survival: a 14 month retrospective review of 100 HIV positive patients receiving antiviral therapy.
CD4 count and viral load monitoring of GPO-vir therapy in the access to care program in Northern Thailand.
CD4 count and viral load-strong, independent predictors of time to death in clade E HIV-infected Thais.
CD4 count as predictor of reactivation of tuberculosis in HIV infection.
CD4 count changes in people interrupting HAART therapy after a CD4 count increase.
CD4 count evolution in HIV-1(+) women: 12 months after delivery in Kinshasa, Zaire.
CD4 count, rate of CD4 decline and risk of death in zidovudine-treated patients.
CD4 counts and AIDS-defining conditions in infants and children with HIV infection.
CD4 counts and beta 2 microglobulin levels in patients with tuberculosis and HIV infection. The CDS/JHU Study Group.
CD4 counts as a surrogate marker in Indian HIV population.
CD4 counts as predictors of Pneumocystis carinii pneumonia in infants and children with HIV infection.
CD4 counts during treatment of herpes simplex infection in HIV-1 infected children.
CD4 counts in Romanian non-vertically HIV-infected children recieving antiretroviral tritherapy.
CD4 cross-linking induces aberrant cytokine secretion. Fas antigen expression and T-cell apoptosis.
CD4 crosslinking (CD4XL) molecule with HIV gp160 induces ras activation and TNF-alpha secretion in CD4+ T cells.
CD4 crosslinking primes resting CD4+ T lymphocytes to undergo Fas dependent apoptosis.
CD4 CTL are protected from infection by macrophage-tropic HIV during antigen presentation through the secretion of endogenous, beta-chemokines.
CD4 decay after discontinuation of virologically successful antiretroviral therapy.
CD4 Disadvantage and Improved Blood Lipids in a Large Controlled 18-Month Trial of Treatment Interruptions (TIs).
CD4 down-modulation can be induced by both non-pathogenic and pathogenic SIV nef alleles.
CD4 dynamics after discontinuation of successful HAART.